ロード中...
Safety, tolerability and pharmacokinetics of higher-dose mizoribine in healthy male volunteers
AIMS: Mizoribine is an oral immunosuppressive agent approved in several countries for prevention of rejection in renal transplantation. Its therapeutic window is based on trough concentrations staying at ≥0.5 but <3 µg ml(−1). It has been postulated that as renal function returns to normal, highe...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Blackwell Publishing Ltd
2007
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2203250/ https://ncbi.nlm.nih.gov/pubmed/17096684 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2006.02779.x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|